World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
96
Citations
52161
World Ranking
1502
National Ranking
576

Michael R. Boyd publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Michael R. Boyd sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 379 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Michael R. Boyd D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Michael R. Boyd sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 96 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Michael R. Boyd is affiliated with the University of South Alabama in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics, and Molecular Biology, with a focus on Oncology, Molecular Biology, Immunology, Polymers and Plastics, and Pharmacology.

Their scholarly contributions include exploration into topics such as Peptidase Inhibition and Analysis, Biochemical and Molecular Research, Pancreatic and Hepatic Oncology Research, Phosphodiesterase function and regulation, Inflammatory mediators and NSAID effects, Mast cells and histamine, and Cancer Immunotherapy and Biomarkers.

Among their recent publications are:

  • PDE5 and PDE10 inhibition activates cGMP/PKG signaling to block Wnt/β-catenin transcription, cancer cell growth, and tumor immunity (2020, Drug Discovery Today)
  • A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer (2024, Cancer Research)
  • A Novel Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth in Mouse Models of GI Cancer (2023, bioRxiv (Cold Spring Harbor Laboratory))
  • CHARACTERIZATION AND CORRELATION OF THE NETWORK CHAIN DENSITY TO THE PROPERTIES OF FLUOROELASTOMER RUBBER (2020, Rubber Chemistry and Technology)
  • A potent and selective pan-RAS inhibitor, ADT-1004, targeting complex KRAS mutations for pancreatic cancer (2024, Journal of Clinical Oncology)

Their frequent coauthors include:

  • Gary A. Piazza
  • Donald J. Buchsbaum
  • Adam B. Keeton
  • Yulia Maxuitenko
  • Jeremy B. Foote

Michael R. Boyd has contributed to multiple publications in venues such as:

  • Journal of Clinical Oncology
  • Drug Discovery Today
  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Rubber Chemistry and Technology

Best Publications

  • New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening

    Philip Skehan;Ritsa Storeng;Dominic Scudiero;Anne Monks

  • Evaluation of a Soluble Tetrazolium/Formazan Assay for Cell Growth and Drug Sensitivity in Culture Using Human and Other Tumor Cell Lines

    Dominic A. Scudiero;Robert H. Shoemaker;Kenneth D. Paull;Anne Monks

  • Some Practical Considerations and Applications of the National Cancer Institute In Vitro Anticancer Drug Discovery Screen

    Michael R. Boyd;Kenneth D. Paull

  • Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE Algorithm

    K. D. Paull;R. H. Shoemaker;L. Hodes;A. Monks

  • Comparison of In Vitro Anticancer-Drug-Screening Data Generated With a Tetrazolium Assay Versus a Protein Assay Against a Diverse Panel of Human Tumor Cell Lines

    L. V. Rubinstein;R. H. Shoemaker;K. D. Paull;R. M. Simon

  • New Soluble-Formazan Assay for HIV-1 Cytopathic Effects: Application to High-Flux Screening of Synthetic and Natural Products for AIDS-Antiviral Activity

    Owen S. Weislow;Rebecca Kiser;Donald L. Fine;John Bader

  • Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development.

    M R Boyd;K R Gustafson;J B McMahon;R H Shoemaker

  • The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum.

    Yoel Kashman;Kirk R. Gustafson;Richard W. Fuller;John H. Cardellina

  • Antineoplastic Agents. 291. Isolation and Synthesis of Combretastatins A-4, A-5, and A-6

    George R. Pettit;Sheo Bux Singh;Michael R. Boyd;Michael R. Boyd;Ernest Hamel;Ernest Hamel

  • Isolation and Characterization of Griffithsin, a Novel HIV-inactivating Protein, from the Red Alga Griffithsia sp.

    Toshiyuki Mori;Barry R. O'Keefe;Raymond C. Sowder;Scott Bringans

  • AIDS-Antiviral Sulfolipids From Cyanobacteria (Blue-Green Algae)

    Kirk R. Gustafson;John H. Cardellina;Richard W. Fuller;Owen S. Weislow

  • Circulins A and B. Novel human immunodeficiency virus (HIV)-inhibitory macrocyclic peptides from the tropical tree Chassalia parvifolia.

    Kirk R. Gustafson;Raymond C. Sowder;Louis E. Henderson;Ian C. Parsons

  • Salicylihalamides A and B, Novel Cytotoxic Macrolides from the Marine Sponge Haliclona sp.

    Karen L. Erickson;John A. Beutler;John H. Cardellina;Michael R. Boyd

  • Antineoplastic agents 322. synthesis of combretastatin A-4 prodrugs.

    G. R. Pettit;C. Temple;V. L. Narayanan;Ravi Varma

  • Antineoplastic agents. 379. Synthesis of phenstatin phosphate.

    George R. Pettit;Brian Toki;Delbert L. Herald;Pascal Verdier-Pinard

  • Biochemical Mechanisms in Chemical-Induced Lung Injury: Roles of Metabolic Activation

    Michael R. Boyd;H. P. Witschi

  • Potent and selective activity of a new carbocyclic nucleoside analog (carbovir: NSC 614846) against human immunodeficiency virus in vitro.

    Robert Vince;Mei Hua;Jay Brownell;Susan Daluge

  • The guttiferones, HIV-inhibitory benzophenones from Symphonia globulifera, Garcinia livingstonei, Garcinia ovalifolia and Clusia rosea

    Kirk R. Gustafson;John W. Blunt;Murray H.G. Munro;Richard W. Fuller

  • PAPUAMIDES A-D, HIV-INHIBITORY AND CYTOTOXIC DEPSIPEPTIDES FROM THE SPONGES THEONELLA MIRABILIS AND THEONELLA SWINHOEI COLLECTED IN PAPUA NEW GUINEA

    R.W.M. van Soest;P.W. Ford;K.R. Gustafson;T.C. Mc Kee

  • Anti-HIV michellamines from Ancistrocladus korupensis.

    Michael R. Boyd;Yali F. Hallock;John H. CardellinaII;Kirk P. Manfredi

  • A Potent Novel Anti-HIV Protein from the Cultured Cyanobacterium Scytonema varium†

    Heidi R. Bokesch;Barry R. O'keefe;Tawnya C. Mckee;Lewis K. Pannell

  • Isolation and structure of the cell growth inhibitory constituents from the Western Pacific marine sponge Axinella sp.

    George R. Pettit;Cherry L. Herald;Michael R. Boyd;Michael R. Boyd;John E. Leet

  • Novel alkaloids from the tropical plant Ancistrocladus abbreviatus inhibit cell killing by HIV-1 and HIV-2.

    Kirk P. Manfredi;John W. Blunt;John H. Cardellina;James B. McMahon

Frequent Co-Authors

George R. Pettit
George R. Pettit Arizona State University
Kirk R. Gustafson
Kirk R. Gustafson National Institutes of Health
John H. Cardellina
John H. Cardellina Montana State University
Gerhard Bringmann
Gerhard Bringmann University of Würzburg
Jean M. Schmidt
Jean M. Schmidt Arizona State University
John A. Beutler
John A. Beutler National Institutes of Health
Robert H. Shoemaker
Robert H. Shoemaker National Institutes of Health
James B. McMahon
James B. McMahon National Institutes of Health
Vijayalakshmi Ravindranath
Vijayalakshmi Ravindranath Indian Institute of Science
Rodney F. Minchin
Rodney F. Minchin University of Queensland

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to various interdisciplinary career paths, many of which can be pursued through online degrees. For those interested in combining science with legal and investigative work, forensic science offers an exciting option. According to forensic career paths and salary data, professionals with a chemistry background can find rewarding roles in criminal investigations and laboratory analysis.

Many students looking for flexible study options consider online programs, but it's important to understand costs. Insights on how much is criminal justice school can help prospective students budget effectively for their education.

For those beginning their academic journey, the best online criminal justice associate degree offers a solid foundation that aligns well with further specialization in chemistry-related legal fields.

Additionally, careers such as paralegal work are accessible with an associate’s degree in conjunction with chemistry or legal studies. The paralegal salary associate's degree information provides valuable insights into the earning potential and scope of this pathway.

Best Scientists Citing Michael R. Boyd

Trending Scientists

Recently Published Articles